Journal Home
Search for

Volume 31, Issue 6, Pages 564-570 (November 2009)


View previous. 10 of 21 View next.

Trends in long-term opioid therapy for noncancer pain among persons with a history of depression

Jennifer Brennan Braden, M.D., M.P.H.aCorresponding Author Informationemail address, Mark D. Sullivan, M.D., Ph.D.a, G. Thomas Rayb, Kathleen Saunders, J.D.c, Joseph Merrill, M.D., M.P.H.d, Michael J. Silverberg, Ph.D, M.P.H.b, Carolyn M. Rutter, Ph.D.c, Constance Weisner, DrPH, M.S.W.be, Caleb Banta-Green, M.P.H., M.S.W, Ph.D.f, Cynthia Campbell, Ph.D.b, Michael Von Korff, Sc.D.c

Received 13 April 2009; accepted 8 July 2009. published online 28 August 2009.

Abstract 

Objective

We report trends in long-term opioid use among patients with a history of depression from two large health plans.

Methods

Using claims data, age- and gender-adjusted rates for long-term (>90 days) opioid use episodes were calculated for 1997–2005, comparing those with and without a depression diagnosis in the prior 2 years. Opioid use characteristics were calculated for those with a long-term episode in 2005.

Results

Incident and prevalent long-term opioid use rates were three times higher in those with a history of depression. Prevalent long-term use per 1000 in patients with a history of depression increased from 69.8 to 125.9 at Group Health and from 84.3 to 117.5 at Kaiser Permanente of Northern California between 1997 and 2005. Those with a history of depression were more likely to receive a higher average daily dose, greater days supply, and Schedule II opioids than nondepressed persons.

Conclusion

Persons with a history of depression are more likely to receive long-term opioid therapy for noncancer pain than those without a history of depression. Results suggest that long-term opioid therapy for noncancer pain is being prescribed to a different population in clinical practice than the clinical trial populations where opioid efficacy has been established.

a Department of Psychiatry and Behavioral Sciences, Box 356560, University of Washington, Seattle, WA 98195-6560, USA

b Division of Research, Kaiser Permanente of Northern California, Oakland, CA 94612, USA

c Center for Health Studies, Group Health Cooperative, Seattle, WA 98101-1448, USA

d Department of Medicine, Box 359780, University of Washington, Seattle, WA 98195-6560, USA

e Department of Psychiatry, University of California, San Francisco, CA 94143-0984, USA

f Alcohol and Drug Abuse Institute, Box 354805, University of Washington, Seattle, WA 98195-6560, USA

Corresponding Author InformationCorresponding author. Tel.: +1 206 543 3925; fax: +1 206 221 5414.

PII: S0163-8343(09)00137-6

doi:10.1016/j.genhosppsych.2009.07.003


View previous. 10 of 21 View next.